标题
Immunohistochemistry Innovations for Diagnosis and Tissue-Based Biomarker Detection
作者
关键词
Dual immunohistochemistry, Multiplex immunohistochemistry, Mutation-specific antibody, BRAF V600E, CD123, IDH1, LEF1, PAX5, TCF4
出版物
Current Hematologic Malignancy Reports
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-07-23
DOI
10.1007/s11899-019-00533-9
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Early T precursor acute lymphoblastic leukaemia/lymphoma shows differential immunophenotypic characteristics including frequent CD 33 expression and in vitro response to targeted CD 33 therapy
- (2019) Haitham Khogeer et al. BRITISH JOURNAL OF HAEMATOLOGY
- Dual Expression of TCF4 and CD123 is Highly Sensitive and Specific For Blastic Plasmacytoid Dendritic Cell Neoplasm
- (2019) Narittee Sukswai et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Bone Marrow Involvement in Patients With Nodular Lymphocyte Predominant Hodgkin Lymphoma
- (2018) Rose Lou Marie C. Agbay et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Comparison of Immunohistochemistry and Direct Sequencing Methods for Identification of the BRAFV600E Mutation in Papillary Thyroid Carcinoma
- (2018) Jong-kyu Kim et al. ANNALS OF SURGICAL ONCOLOGY
- The role of IDH mutations in acute myeloid leukemia
- (2018) Guillermo Montalban-Bravo et al. Future Oncology
- Concordance in BRAF V600E status over time in malignant melanoma and corresponding metastases
- (2018) Line B Nielsen et al. HISTOPATHOLOGY
- Clinicopathologic and molecular features in hairy cell leukemia-variant: single institutional experience
- (2018) Evgeniya A. Angelova et al. MODERN PATHOLOGY
- Investigation of BRAF V600E detection approaches in papillary thyroid carcinoma
- (2018) Dan Chen et al. PATHOLOGY RESEARCH AND PRACTICE
- Accuracy of diagnosing mantle cell lymphoma and identifying its variants on fine-needle aspiration biopsy
- (2018) Michelle Foshat et al. CANCER CYTOPATHOLOGY
- SOHO State of the Art Update and Next Questions: IDH Therapeutic Targeting in AML
- (2018) Courtney D. DiNardo et al. Clinical Lymphoma Myeloma & Leukemia
- CD123 expression patterns and selective targeting with a CD123-specific antibody-drug conjugate (IMGN632) in acute lymphoblastic leukemia
- (2018) Evgeniya Angelova et al. HAEMATOLOGICA
- Distinguishing thymoma from T-lymphoblastic leukaemia/lymphoma: a case-based evaluation
- (2018) Prajwal Boddu et al. JOURNAL OF CLINICAL PATHOLOGY
- Histone deacetylase inhibitor targets CD123/CD47-positive cells and reverse chemoresistance phenotype in acute myeloid leukemia
- (2018) Bowen Yan et al. LEUKEMIA
- Blastic Plasmacytoid Dendritic Cell Neoplasm
- (2018) Joseph D. Khoury Current Hematologic Malignancy Reports
- Prognostic impact of CD5 expression in diffuse large B-cell lymphoma in patients treated with rituximab-EPOCH
- (2017) Beenu Thakral et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Angioimmunoblastic T-Cell Lymphoma
- (2017) Alessandro Broccoli et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Langerhans cell histiocytosis associated with lymphoma: an incidental finding that is not associated with BRAF or MAP2K1 mutations
- (2017) Sergio Pina-Oviedo et al. MODERN PATHOLOGY
- The histopathology of Erdheim–Chester disease: a comprehensive review of a molecularly characterized cohort
- (2017) Neval Ozkaya et al. MODERN PATHOLOGY
- Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai–Dorfman disease
- (2017) Sofia Garces et al. MODERN PATHOLOGY
- Cost-effectiveness of IDH testing in diffuse gliomas according to the 2016 WHO classification of tumors of the central nervous system recommendations
- (2017) John C DeWitt et al. NEURO-ONCOLOGY
- Therapeutic Antibodies: What Have We Learnt from Targeting CD20 and Where Are We Going?
- (2017) Michael J. E. Marshall et al. Frontiers in Immunology
- IDH mutations in cancer and progress toward development of targeted therapeutics
- (2016) L. Dang et al. ANNALS OF ONCOLOGY
- Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: a high-risk subtype
- (2016) N. Jain et al. BLOOD
- A Druggable TCF4- and BRD4-Dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm
- (2016) Michele Ceribelli et al. CANCER CELL
- CD5 expression promotes IL-10 production through activation of the MAPK/Erk pathway and upregulation of TRPC1 channels in B lymphocytes
- (2016) Soizic Garaud et al. Cellular & Molecular Immunology
- Specific immunohistochemical detection of the BRAF V600E mutation in primary and metastatic papillary thyroid carcinoma
- (2016) Xiaoli Zhu et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Immunohistochemistry as a reliable method for detection of BRAF-V600E mutation in melanoma: a systematic review and meta-analysis of current published literature
- (2016) Muhammad Ahmed Farooq Anwar et al. JOURNAL OF SURGICAL RESEARCH
- Immunohistochemistry forBRAFV600E in the Differential Diagnosis of Hairy Cell Leukemia vs Other Splenic B-Cell Lymphomas
- (2015) Samir Turakhia et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Comparison of Next-generation Sequencing Mutation Profiling With BRAF and IDH1 Mutation-specific Immunohistochemistry
- (2015) Kausar J. Jabbar et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- TP53 overexpression is an independent adverse prognostic factor inde novomyelodysplastic syndromes with fibrosis
- (2015) Sanam Loghavi et al. BRITISH JOURNAL OF HAEMATOLOGY
- BRAF Immunohistochemistry Using Clone VE1 is Strongly Concordant with BRAFV600E Mutation Test in Papillary Thyroid Carcinoma
- (2015) Jung-Soo Pyo et al. ENDOCRINE PATHOLOGY
- Utility of BRAF V600E Immunohistochemistry Expression Pattern as a Surrogate of BRAF Mutation Status in 154 Patients with Advanced Melanoma
- (2015) Michael T. Tetzlaff et al. HUMAN PATHOLOGY
- New Developments in the Pathogenesis and Therapeutic Targeting of the IDH1 Mutation in Glioma
- (2015) Lilia Dimitrov et al. International Journal of Medical Sciences
- LEF1: a highly specific marker for the diagnosis of chronic lymphocytic B cell leukaemia/small lymphocytic B cell lymphoma
- (2015) Thomas Menter et al. JOURNAL OF CLINICAL PATHOLOGY
- CD123 immunostaining patterns in systemic mastocytosis: differential expression in disease subgroups and potential prognostic value
- (2015) A Pardanani et al. LEUKEMIA
- CD5-positive follicular lymphoma: clinicopathologic correlations and outcome in 88 cases
- (2015) Yu Li et al. MODERN PATHOLOGY
- Assessment of BRAF V600E Status in Colorectal Carcinoma: Tissue-Specific Discordances between Immunohistochemistry and Sequencing
- (2015) J. S. Estrella et al. MOLECULAR CANCER THERAPEUTICS
- BRAF V600E mutation-specific antibody: A review
- (2015) Lauren L. Ritterhouse et al. SEMINARS IN DIAGNOSTIC PATHOLOGY
- BRAFkinase domain mutations are present in a subset of chronic myelomonocytic leukemia with wild-typeRAS
- (2014) Liping Zhang et al. AMERICAN JOURNAL OF HEMATOLOGY
- Chance identification of synchronous hairy cell leukemia and plasma cell myeloma in a potential HSC donor
- (2014) X. Zhao et al. BLOOD
- Specific monoclonal antibodies against IDH1/2 mutations as diagnostic tools for gliomas
- (2014) Yukinari Kato Brain Tumor Pathology
- TET2mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrow
- (2013) Khaled Alayed et al. AMERICAN JOURNAL OF HEMATOLOGY
- Immunohistological recognition of cyclin D1 expression by non-lymphoid cells among lymphoid neoplastic cells
- (2013) Zainalabideen Abdulla et al. APMIS
- Comparison of 2 monoclonal antibodies for immunohistochemical detection of BRAF V600E mutation in malignant melanoma, pulmonary carcinoma, gastrointestinal carcinoma, thyroid carcinoma, and gliomas
- (2013) Caitlin Ann Routhier et al. HUMAN PATHOLOGY
- Clinicopathologic Features of B-Cell Lineage Neoplasms With Aberrant Expression of CD3
- (2012) Jennifer L. Oliveira et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Distinct requirement for an intact dimer interface in wild-type, V600E and kinase-dead B-Raf signalling
- (2012) Michael Röring et al. EMBO JOURNAL
- Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody
- (2011) David Capper et al. ACTA NEUROPATHOLOGICA
- Clinical Implications of Novel Mutations in Epigenetic Modifiers in AML
- (2011) Omar Abdel-Wahab et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Nuclear overexpression of lymphoid-enhancer-binding factor 1 identifies chronic lymphocytic leukemia/small lymphocytic lymphoma in small B-cell lymphomas
- (2011) Bevan Tandon et al. MODERN PATHOLOGY
- Differentiation of Chronic Lymphocytic Leukemia B Cells into Immunoglobulin Secreting Cells Decreases LEF-1 Expression
- (2011) Albert Gutierrez et al. PLoS One
- Acute Myeloid Leukemia WithIDH1orIDH2Mutation
- (2010) Keyur P. Patel et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Monoclonal antibody specific for IDH1 R132H mutation
- (2009) David Capper et al. ACTA NEUROPATHOLOGICA
- T Cell Activation
- (2009) Jennifer E. Smith-Garvin et al. Annual Review of Immunology
- A monoclonal antibody IMab-1 specifically recognizes IDH1R132H, the most common glioma-derived mutation
- (2009) Yukinari Kato et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- CD20+ T-cell Lymphoma
- (2008) Aliyah Rahemtullah et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Transcription Factor E2-2 Is an Essential and Specific Regulator of Plasmacytoid Dendritic Cell Development
- (2008) Babacar Cisse et al. CELL
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started